Effect of oxcarbazepine pretreatment on convulsive activity and brain damage induced by kainic acid administration in rats


Por: Ayala-Guerrero F., Mexicano G., Campos-Sepúlveda E., Romero R.M., Reynoso-Robles R., González-Maciel A.

Publicada: 1 nov 2008
Resumen:
Temporal lobe epilepsy is one of the most common types of epilepsy. Progress in the understanding and treatment of this type of epilepsy would be greatly facilitated by the availability of an animal model, which reproduced the behavioral and electrographic features of this condition. In this context, kainic acid (KA, 2-carboxy-3-carboxymethyl-4-isopropenylpyrrolidine) administration causes a syndrome characterized by an acute status epilepticus and subsequent brain damage similar to that in temporal lobe epilepsy of humans. The aim of the present study was to investigate whether oxcarbazepine (10,11-dihydro-10-oxo-5 H -dibenz(b,f)azepine-5-carboxamide), an antiepileptic drug, protects against both epileptic activity and brain damage induced by KA administration. Chronically implanted adult male Wistar rats were polygraphically recorded during 10 continuous hours under 4 different conditions: a) control, b) after KA administration alone, c) after KA administration in oxcarbazepine pretreated animals and d) after the administration of oxcarbazepine alone. Animals treated with KA alone presented behavioral and electrophysiological convulsive activity as well as brain damage. Latency of seizure installation was lengthened significantly and convulsive activity was slightly reduced, however, brain damage was still present in oxcarbazepine pretreated animals. Administration of oxcarbazepine alone induced a hypnotic behavior and brain damage was also present. © 2007 Elsevier Inc. All rights reserved.

Filiaciones:
Ayala-Guerrero F.:
 Univ Nacl Autonoma Mexico, Fac Psicol, Fac Med, Mexico City 04510, DF, Mexico

Mexicano G.:
 Univ Nacl Autonoma Mexico, Fac Psicol, Fac Med, Mexico City 04510, DF, Mexico

Campos-Sepúlveda E.:
 Univ Nacl Autonoma Mexico, Fac Psicol, Fac Med, Mexico City 04510, DF, Mexico

Romero R.M.:
 Instituto Nacional de Pediatría México, Mexico

Reynoso-Robles R.:
 Instituto Nacional de Pediatría México, Mexico

González-Maciel A.:
 Instituto Nacional de Pediatría México, Mexico
ISSN: 10956433
Editorial
ELSEVIER SCIENCE INC, 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA, Estados Unidos America
Tipo de documento: Article
Volumen: 151 Número: 3
Páginas: 471-476
WOS Id: 000260665000021
ID de PubMed: 17669675

MÉTRICAS